News
Shape-Shifting Nanoparticles Flip from Sphere to Net in Response to Tumor Signal
May 29, 2013 9:44 am | by University of California - San Diego | CommentsScientists at the University of California, San Diego, have designed tiny spherical particles to float easily through the bloodstream after injection, then assemble into a durable scaffold within diseased tissue. An enzyme produced by a specific type of tumor can trigger the transformation of the spheres into netlike structures that accumulate at the site of a cancer, the team reports in the journal Advanced Materials this week.
Digital Chest Tomosynthesis Possible Lung Cancer Screening Tool
May 29, 2013 9:37 am | by International Association for the Study of Lung Cancer | CommentsDigital chest tomosynthesis (DT), a tomographic technique, may offer an alternative to CT screening. A recent study published in the Journal of Thoracic Oncology (JTO), concludes that digital chest tomosynthesis holds promise as a first-line lung cancer screening tool.
New Diagnostic Technology May Lead to Individualized Treatments for Prostate Cancer
May 29, 2013 9:35 am | by Cedars-Sinai Medical Center | CommentsA research team jointly led by scientists from Cedars-Sinai Medical Center and the University of California, Los Angeles, have enhanced a device they developed to identify and "grab" circulating tumor cells, or CTCs, that break away from cancers and enter the blood, often leading to the spread of cancer to other parts of the body.
Global Ultrasound Market to Climb in Next Few Years, Thanks to Emerging Markets
May 29, 2013 9:32 am | by IMS Research | CommentsThe global ultrasound market is forecast to grow by 27 percent over the next five years despite ongoing economic challenges, with emerging healthcare markets key to sustaining future global growth, according to a new report entitled “The World Market for Ultrasound Imaging Equipment – 2013” from IMS Research, now part of IHS Inc. (NYSE: IHS).
Advanced Paper Could be Foundation for Inexpensive Biomedical and Diagnostic Devices
May 29, 2013 9:29 am | by John Toon, Georgia Tech | CommentsPaper is known for its ability to absorb liquids, making it ideal for products such as paper towels. But by modifying the underlying network of cellulose fibers, etching off surface “fluff” and applying a thin chemical coating, researchers have created a new type of paper that repels a wide variety of liquids – including water and oil.
Small Molecule Could Have Big Impact on Cancer
May 29, 2013 9:23 am | by University of Texas at Dallas | CommentsDr. Jung-Mo Ahn, associate professor of chemistry at The University of Texas at Dallas, has designed and synthesized a novel small molecule that might become a large weapon in the fight against prostate cancer. Ahn and his colleagues at UT Southwestern Medical Center describe the design of the molecule as well as laboratory tests that show its effectiveness at blocking the cancer-promoting function of proteins called androgen receptors.
Vycor Issued Strategically Significant U.S. Patent for Its ViewSite(TM) Brain Access System (VBAS)
May 29, 2013 8:30 am | by The Associated Press | CommentsVycor Medical, Inc. ("Vycor") (OTCBB: VYCO), a medical device company with a suite of FDA cleared products, announced that U.S. patent #12/545719, which relates to its ViewSite Brain Access System ("VBAS"), has been issued. The claims of this patent cover methods for accessing a...
Study of the Use of Control Catheters with the Sensei X Robotic System for the Treatment of Atrial Fibrillation
May 29, 2013 8:00 am | by The Associated Press | CommentsHansen Medical, Inc., a global leader in intravascular robotics, today announced that it has received conditional approval from the U.S. Food and Drug Administration to change the study design of its ARTISAN-AF Trial, a pivotal clinical trial evaluating the use of Hansen Medical's Artisan® family of Control Catheters with its Sensei® X Robotic Catheter System for treatment of Atrial Fibrillation, the most common cardiac arrhythmia.
Teleflex Announces European Market Clearance for its Arrow® GPSCath® Balloon Dilatation Catheter
May 29, 2013 7:30 am | by Business Wire | CommentsTeleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced that its subsidiary Hotspur Technologies, Inc., which Teleflex acquired in June 2012, completed CE marking requirements to market the company’s Arrow ® GPSCath ® Balloon Dilatation Catheters to the European Union.
ZELTIQ Aesthetics Wins Two Major Legal Decisions
May 28, 2013 12:45 pm | by Globe Newswire | CommentsZELTIQ® Aesthetics, Inc. (Nasdaq:ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that it prevailed in two major legal cases.
Covidien Nellcor Pulse Oximeters Receive FDA 510(k) Clearance with Labeling for Use in Newborn Screening for Critical Congenital Heart Disease
May 28, 2013 12:35 pm | by Covidien | CommentsCovidien’s new CCHD labeling was introduced as part of the FDA 510(k)-cleared labeling for motion tolerant Nellcor pulse oximeters. In 2011, the U.S. Department of Health and Human Services added CCHD screening to the Federal Recommended Uniform Screening Panel Guidelines.
PA Girl's Parents Challenge Lung Donor Rule
May 28, 2013 12:30 pm | by Ron Todt, Associated Press | CommentsThe parents of a 10-year-old Pennsylvania girl who has been waiting for a lung transplant for a year and a half are calling for a change in the policy governing organ transplants that they say has prevented their increasingly sick daughter from getting life-saving surgery.
FDA Approves Blood Test to Diagnose Diabetes
May 28, 2013 10:56 am | by The Associated Press | CommentsThe Food and Drug Administration said Thursday it approved a new blood test from Roche to help doctors diagnose diabetes. The Cobas Integra 800 is a blood test that measures a patient's average blood sugar level over the previous three months. In particular, the test measures an oxygen-carrying blood component known as hemoglobin.
Mom's Obesity Surgery May Help Break Cycle in Kids
May 28, 2013 10:54 am | by Lauran Neergaard, AP Medical Writer | CommentsObese mothers tend to have kids who become obese. Now provocative research suggests weight-loss surgery may help break that unhealthy cycle in an unexpected way — by affecting how their children's genes behave. In a first-of-a-kind study, Canadian researchers tested children born to obese women, plus their brothers and sisters who were conceived after the mother had obesity surgery.
Valeant to Buy Bausch + Lomb for $8.7B
May 28, 2013 10:29 am | by Linda A. Johnson, AP Business Writer | CommentsCanadian drugmaker Valeant Pharmaceuticals has agreed to pay $8.7 billion to buy Bausch + Lomb, one of the world's best-known makers of contact lenses, in a massive expansion of Valeant's smaller ophthalmology business. Valeant said Monday that the cash deal will help it capitalize on increasing demand for contact lenses and other products because of aging populations, growing demand in emerging markets and increasing rates of diabetes.
